The Patent Finder

Isogenis, Inc.

Also on record
Records under this name other than the patents Isogenis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to Isogenis, Inc.

PatentTitleStatus Expires Confidence
US 5,242,687Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
Term ended
Term ended no later than Sep 7, 2013 · Low confidence
Term endedTerm ended no later than Sep 7, 2013Low confidence
US 5,601,828CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment
Term ended
Term ended no later than Feb 11, 2017 · Low confidence
Term endedTerm ended no later than Feb 11, 2017Low confidence
US 5,623,056CDS derivatives and methods of use for cellular modulation and enhancement of cellular engraftment
Term ended
Term ended no later than Apr 22, 2017 · Low confidence
Term endedTerm ended no later than Apr 22, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited